Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Viking Therapeutics 0, Structure Therapeutics 0.
Viking Therapeutics vs Structure Therapeutics: Revenue Comparison
Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are peers in GLP-1. Viking Therapeutics reported revenue of $0 as of Q2 2026, compared with $0 for Structure Therapeutics.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Viking Therapeutics, Structure Therapeutics.| Metric | Viking Therapeutics | Structure Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $0 | $0 |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | $-133.00M | $-119.00M |
| Net Income | $-128.00M | $-106.00M |
| R&D Expense | $116.00M | $100.00M |
| Earnings Per Share | -$1.1 | -$1.47 |
| Gross Margin | - | - |
| Operating Margin | - | - |
| Net Profit Margin | - | - |
| Free Cash Flow | $-125.00M | $-120.00M |
| Cumulative Free Cash Flow | $-872.00M | $-589.00M |
| Operating Cash Flow | $-125.00M | $-120.00M |
| Cash & Equivalents | $126.00M | $273.00M |